It's important to think things through before signing up for benefits -- especially if you're claiming them early.
Shares of e-commerce technology-darling Shopify (NYSE: SHOP) were down 7.6% today as of 11:50 a.m. ET. The broader market indices had clawed back steep early losses, but no such luck for Shopify, as richly valued names continue to get punished. The drop is particularly confounding because Shopify just inked a deal with Chinese e-commerce giant JD.com (NASDAQ: JD).
Shares of SunPower (NASDAQ: SPWR) slumped 15.8% in early trading Friday. SunPower released preliminary fourth-quarter earnings after the market closed on Thursday and investors were underwhelmed. One concern in the report was that SunPower was replacing third-party connectors in its light commercial value-added reseller and commercial and industrial solutions systems (CIS) because the company said it had found a cracking issue in the connectors.
On Wednesday, Jan. 26, Tesla (NASDAQ: TSLA) will report its Q4 earnings for fiscal year 2021 -- so the fact that Tesla stock is falling today doesn't portend particularly well. As of 11 a.m. ET, Tesla stock is trading down 2.5% -- about five times worse than the decline on the broader Nasdaq index. Why Tesla stock is down isn't immediately clear.
Shares of Palantir Technologies (NYSE: PLTR) fell as much as 7% on Friday morning after a Wall Street analyst cut his price target for the data analytics stock. The analyst isn't questioning the quality of the business, but valuation is an open question in this environment. Palantir, as my Motley Fool colleague Keith Noonan noted yesterday, is a stock that has been moving in conjunction with the Nasdaq Composite, and so perhaps it should be no surprise the stock got off to a bad start on Friday morning as the broader market traded down.
The surface of the S&P 500 makes markets look calm. But look down just one layer, and you see some serious pain.
Shares of Huntington Bancshares (NASDAQ: HBAN) are trading 7.3% down as of 11:00 a.m. ET today after reporting earnings results for the fourth quarter and full year of 2021. Huntington reported fourth-quarter earnings per share (EPS) of $0.26 on total revenue of $1.65 billion, missing on analyst estimates for both EPS and revenue. "We enter 2022 increasingly confident in our outlook for growth in revenue and earnings," Huntington president and CEO Steve Steinour said in a statement.
The yield-sensitive Nasdaq Composite Index on Wednesday logs its first close in correction territory since March. Here's what history says happens next.
Investors looking to add growth stocks to their portfolios this month shouldn't miss these names.
BioNTech (NASDAQ: BNTX) stock is taking the worst drubbing, down 19.7% as of the market close on Thursday. Moderna's (NASDAQ: MRNA) shares were sinking 17.2%. Novavax (NASDAQ: NVAX) and Ocugen (NASDAQ: OCGN) stocks were falling 18.5% and 16.2%, respectively.
Here are three dividend-paying stocks that can provide investors with a rare trifecta of value, dividend growth potential, and quality. Let's take a closer look at these three stocks Wall Street appears to be sleeping on. Investors would be wise to consider buying shares of real estate investment trust (REIT) Realty Income (NYSE: O) before the market warms up to it.
In recent years, Disney (NYSE: DIS) animation has been enjoying something of a renaissance. Many have likened the recent string of hits to Disney's critically and commercially successful period that began in the late 1980s. Each was an instant classic and added to Disney's already sizable treasure trove of intellectual property.
Rivian Automotive (NASDAQ: RIVN) isn't giving its shareholders any respite -- the electric vehicle (EV) stock was down by 22.6% for the week as of 10:30 a.m. ET Friday, according to data provided by S&P Global Market Intelligence. At this point, Rivian has declined by a whopping 41% year to date. Given that the market had already been warned, investors shouldn't have been surprised when Rivian announced the actual numbers.
Novavax has been both a promising and frustrating stock to own recently. It's promising in the sense that its COVID-19 vaccine candidate could give the company a slice of what's proving to be a very large pie. The frustrating part about Novavax is that it has continually pushed back its schedule for applying to the U.S. Food and Drug Administration (FDA) for an Emergency Use Authorization (EUA).
In this article, we will discuss the 10 stocks that Izzy Englander has sold in Q3. You can skip our detailed analysis of his hedge fund and recent developments, and go directly to read Billionaire Izzy Englander is Selling These 5 Stocks. Israel Englander is one of the most prominent hedge fund managers of all […]
Select analysts and investment banks see "high" return potential for these cannabis stocks.
A Piper Sandler analyst points to rising costs and decelerating revenue growth as the leading causes for the lower value.
Yahoo Finance's Julie Hyman and Brian Sozzi discuss Netflix's stock taking a dip, subscriber growth, the company's fourth quarter earnings, and the outlook for the streaming platform.
If an investor isn't careful, they can wind up buying stocks at valuations that look too good to be true. Here are three undervalued stocks for investors to consider buying right now. BlackRock (NYSE: BLK) is the largest asset manager in the world.
A Bank of America analyst cut his price target on the stock in half on Wednesday, but hope springs eternal.
Shares of Netflix plunged more than 20% in early trading Friday after the company reported fourth quarter results that reflected weakening subscriber additions.